StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)

Close on Nov 16, 2026Market cap $1.52BP/E –Yield –

GeneDx operating margin

Operating margin is operating income as a percentage of revenue.

GeneDx's operating margin for the twelve months ending Jun 30, 2026 was -20.3%. For fiscal 2025 it was -3.1%, against -7.6% the year before. The highest annual figure on record is -3.1% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3.1%+4.5
FY2024Dec 31, 2024-7.6%+81.6
FY2023Dec 31, 2023-89.2%+195.3
FY2022Dec 31, 2022-284.5%−74.2
FY2021Dec 31, 2021-210.3%−75.3
FY2020Dec 31, 2020-134.9%−119.4
FY2019Dec 31, 2019-15.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-15.3%−24.0
Q1 FY2026Mar 31, 2026-56.2%−51.0
Q4 FY2025Dec 31, 2025-11.8%−21.0
Q3 FY2025Sep 30, 2025-2.8%+7.3
Q2 FY2025Jun 30, 20258.7%+23.7
Q1 FY2025Mar 31, 2025-5.2%+16.7
Q4 FY2024Dec 31, 20249.2%+53.9
Q3 FY2024Sep 30, 2024-10.1%+70.5
Q2 FY2024Jun 30, 2024-15.0%+91.0
Q1 FY2024Mar 31, 2024-21.9%+118.0
Q4 FY2023Dec 31, 2023-44.7%+484.9
Q3 FY2023Sep 30, 2023-80.6%+28.5
Q2 FY2023Jun 30, 2023-106.0%+343.7
Q1 FY2023Mar 31, 2023-139.9%+25.6
Q4 FY2022Dec 31, 2022-529.6%−329.2
Q3 FY2022Sep 30, 2022-109.1%+95.3
Q2 FY2022Jun 30, 2022-449.7%−353.0
Q1 FY2022Mar 31, 2022-165.6%+140.8
Q4 FY2021Dec 31, 2021-200.3%−4.8
Q3 FY2021Sep 30, 2021-204.4%−59.3
Q2 FY2021Jun 30, 2021-96.7%+16.8
Q1 FY2021Mar 31, 2021-306.3%−248.9
Q4 FY2020Dec 31, 2020-195.5%–
Q3 FY2020Sep 30, 2020-145.1%–
Q2 FY2020Jun 30, 2020-113.5%–
Q1 FY2020Mar 31, 2020-57.4%–

More GeneDx figures

See a number that looks wrong?